SM Kymes, MA Kass, DR Anderson, JP Miller … - American journal of ophthalmology, 2006 - Elsevier The incremental cost-effectiveness ratios for treatment of people with ocular
hypertension were $3670 per quality adjusted life-year (QALY) for the Treat
≥5% threshold and $42,430/QALY for the Treat ≥2% threshold. “Treat ... Cited by 16 - Related articles - All 3 versions
SM KYMES, BS LEE - Optometry & Vision Science, 2007 - journals.lww.com The use of preference-based measures of quality of life represents the
application of principles of decision theory and welfare economics to the
measurement of health-related concepts. In this Perspective, we present the ... Cited by 5 - Related articles - BL Direct - All 3 versions
S Kymes, A Azuara-Blanco - Guidelines on Design and Reporting of Glaucoma …, 2009 - books.google.com Guidelines for economic evaluation of glaucoma surgical trials Steven Kymes and
Augusto Azuara-Blanco Committee members: Oscar Albis-Donado, Khaled BenAmor,
Jennifer Burr, Paul Chew and Ravi Thomas Summary Points As the cost of care ... Related articles
KD Frick, RW Massof - Archives of Ophthalmology, 2009 - Am Med Assoc Cost-effectiveness studies in health care inform policy decisions, particularly
with respect to allocation of health care resources. For example, if the number
of cataract surgeries performed is limited by the availability of surgeons, ... Related articles - All 3 versions